Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Novartis evaluates SDZ-267-489 and analogues for increasing HDL cholesterol

Sep. 15, 1997

Potent GH secretagogues synthesized at Merck & Co.

Sep. 15, 1997

Kirin's TPO enters phase II in several Asian countries

Sep. 15, 1997

Cannabinoid receptor ligand shows synergistic hematopoietic effects in vitro

Sep. 12, 1997

Kampo medicine with hypolipidemic and antiatherosclerotic effects

Sep. 12, 1997

Focus on diabetes research in the U.S.

Sep. 12, 1997

Oxygent enhances oxygenation more effectively than blood in surgical patients

Sep. 11, 1997

SKB patents several series of vitronectin receptor antagonists

Sep. 11, 1997

Agents for enhancing erythropoiesis prepared at SmithKline Beecham

Sep. 10, 1997

PolyHeme blood substitute advances to phase III

Sep. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...